Johnson Investment Counsel Inc Zoetis Inc. Transaction History

Johnson Investment Counsel Inc

$9.44 Billion
Q2 2024

A detailed history of Johnson Investment Counsel Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 529,649 shares of ZTS stock, worth $96 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

529,649

Previous 533,384 0.7%

Holding current value

$96 Million

Previous $90.3 Million 1.74%

% of portfolio

0.97%

Previous 0.99%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$145.54 - $178.83 $543,591 - $667,930	-3,735 Reduced 0.7%	529,649 $91.8 Million
Q1 2024 May 09, 2024	SELL	$165.67 - $199.94 $2.9 Million - $3.5 Million	-17,486 Reduced 3.17%	533,384 $90.3 Million
Q4 2023 Feb 07, 2024	SELL	$151.44 - $200.09 $3.87 Million - $5.12 Million	-25,576 Reduced 4.44%	550,870 $109 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $8.94 Million - $10.3 Million	-53,492 Reduced 8.49%	576,446 $100 Million
Q2 2023 Aug 10, 2023	SELL	$160.94 - $186.23 $3.97 Million - $4.59 Million	-24,664 Reduced 3.77%	629,938 $108 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $1.56 Million - $1.87 Million	-10,693 Reduced 1.61%	654,602 $109 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $4.91 Million - $5.89 Million	37,431 Added 5.96%	665,295 $97.5 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1.9 Million - $2.34 Million	12,816 Added 2.08%	627,864 $93.1 Million
Q2 2022 Aug 15, 2022	BUY	$155.97 - $200.09 $3.13 Million - $4.02 Million	20,073 Added 3.37%	615,048 $106 Million
Q1 2022 May 11, 2022	BUY	$181.39 - $234.03 $1.65 Million - $2.13 Million	9,107 Added 1.55%	594,975 $112 Million
Q4 2021 Feb 15, 2022	SELL	$193.69 - $247.03 $2.04 Million - $2.6 Million	-10,518 Reduced 1.76%	585,868 $143 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $267,277 - $296,082	1,412 Added 0.24%	596,386 $116 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $359,193 - $433,128	2,304 Added 0.39%	594,974 $111 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $2.4 Million - $2.82 Million	16,668 Added 2.89%	592,670 $93.3 Million
Q4 2020 Feb 12, 2021	SELL	$157.07 - $174.35 $114,346 - $126,926	-728 Reduced 0.13%	576,002 $95.3 Million
Q3 2020 Nov 16, 2020	SELL	$137.1 - $165.37 $2.95 Million - $3.55 Million	-21,484 Reduced 3.59%	576,730 $95.4 Million
Q2 2020 Aug 13, 2020	SELL	$111.92 - $142.53 $70.4 Million - $89.7 Million	-629,324 Reduced 51.27%	598,214 $82 Million
Q1 2020 May 20, 2020	BUY	$92.66 - $144.94 $55.7 Million - $87.2 Million	601,406 Added 96.05%	1,227,538 $154 Million
Q4 2019 Feb 13, 2020	SELL	$116.25 - $133.25 $8,718 - $9,993	-75 Reduced 0.01%	626,132 $82.9 Million
Q3 2019 Nov 14, 2019	SELL	$112.57 - $128.43 $1.69 Million - $1.93 Million	-15,026 Reduced 2.34%	626,207 $78 Million
Q2 2019 Aug 14, 2019	SELL	$97.98 - $114.28 $668,223 - $779,389	-6,820 Reduced 1.05%	641,233 $72.8 Million
Q1 2019 May 13, 2019	BUY	$81.56 - $100.67 $1.41 Million - $1.74 Million	17,259 Added 2.74%	648,053 $65.2 Million
Q4 2018 Feb 13, 2019	SELL	$79.28 - $95.27 $991,792 - $1.19 Million	-12,510 Reduced 1.94%	630,794 $54 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $417,500 - $466,150	-5,000 Reduced 0.77%	643,304 $58.9 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $1.17 Million - $1.3 Million	-14,592 Reduced 2.2%	648,304 $55.2 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $1.83 Million - $2.17 Million	-25,607 Reduced 3.72%	662,896 $55.4 Million
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $2.45 Million - $2.82 Million	-38,707 Reduced 5.32%	688,503 $49.6 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $43.4 Million - $47.6 Million	727,210	727,210 $46.4 Million

Others Institutions Holding ZTS

# of Institutions

1,921

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Zoetis Inc. Transaction History